From the strategic update in March 2021.
Personally, I'm very interested to see if Bisantrene inhibits FTO in non-cancerous cells and how that effects the downstream expression of genes and the impact that has on cellular function, because there have been a couple non-cancerous diseases linked to overexpression of FTO. I don't know how much 'low-cost' is, but I believe the cost to reward ratio is worth taking a look at.
- Forums
- ASX - By Stock
- RAC
- Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene
Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene, page-36
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.52 |
Change
0.000(0.00%) |
Mkt cap ! $258.9M |
Open | High | Low | Value | Volume |
$1.53 | $1.53 | $1.52 | $7.823K | 5.146K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1270 | $1.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.54 | 300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 404 | 1.515 |
3 | 10933 | 1.510 |
4 | 5192 | 1.505 |
6 | 27696 | 1.500 |
2 | 12950 | 1.495 |
Price($) | Vol. | No. |
---|---|---|
1.545 | 571 | 1 |
1.575 | 8227 | 1 |
1.580 | 6715 | 2 |
1.595 | 12136 | 1 |
1.600 | 33469 | 3 |
Last trade - 10.58am 20/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |